Before we dig into this week's news and events, we would like to express our gratitude for all that you do and wish you all a happy and healthy Thanksgiving.
Stay safe! |
|
In This Week’s Update:
- New Cohort Discovery Tools Available Via TriNetX
- Creating Successful Institutional Culture Change
- Promoting Health Equity via Dissemination and Implementation
- UR CTSI Seminar: Feasibility & Acceptability of Enhanced Dialysis Education
- ACTS Translational Science 2021 Meeting: Abstracts Due
- ACTS Workshop: Developing a Five-Year Career Plan
- Translational Science Interagency Fellowship
- Pilot Awards from Rochester Roybal Center & UR Aging Institute
- RocHealthData Explores Native American Health Disparities
- URMC Startup to Develop Neurological Therapies
- Funding Opportunities
|
|
New Cohort Discovery Tools Available to UR Researchers Via TriNetX
University of Rochester researchers can now access a new set of analytic tools and an expanded network database of over 60 million patients through TriNetX, a cohort discovery tool launched at the university last year. The Research Network and Analyze features make TriNetX an even more powerful tool to help researchers determine study feasibility and to generate and explore new hypotheses.
|
|
Webinar: Creating Successful Institutional Culture Change Initiatives at Academic Medical Centers
This webinar, hosted by the Association of American Medical Colleges will explore culture change initiatives in the context of a basic science setting. A panel of inclusion and diversity leaders at academic medical centers, including UR CTSI Director of Diversity and Inclusion John P Cullen, Ph.D., will describe and critique their own initiatives, and share their initiative’s effects.
Date: Tuesday, November 24
Time: 2:00 – 3:00 pm
|
|
Webinar: Promoting Health Equity Using Dissemination and Implementation - Opportunities and Challenges
Kevin Fiscella M.D., M.P.H., professor and co-director of the Research Division in the Department of Family Medicine at URMC, will discuss the critical role of health equity in the generation and use of research evidence, and efforts to reduce health disparities through dissemination & implementation.
Date: Wednesday, November 25
Time: 3:00 – 4:00 pm
|
|
UR CTSI Seminar: Feasibility & Acceptability of Enhanced Dialysis Education
Fahad Saeed, M.B., B.S., a nephrologist and palliative care specialist at URMC, will discuss the work completed during his UR CTSI Career Development Award (KL2). Register to join his talk, titled "Feasibility & Acceptability of Enhanced Dialysis Education Intervention for Chronic Kidney Disease Patients ≥ 75 Years of Age and Their Caregivers."
Date: Thursday, December 3
Time: 12:00 – 12:30 pm
|
|
ACTS Translational Science 2021 Meeting: Abstracts Due
The Association for Clinical and Translational Science (ACTS) 2021 meeting, scheduled for March 30 – April 2, is now accepting abstracts for presentations (due Wednesday, December 2). Detailed submission instructions and helpful guidelines can be found on the ACTS website.
|
|
ACTS Workshop: Developing a Five-Year Career Plan
This webinar, hosted by the Association of Clinical and Translational Science (ACTS), will discuss what trainees need to be successful scientists, how to prioritize tasks and how to view themselves as leaders. The workshop includes completing a self-analysis, setting goals, planning and implementing their career plan with a timeline and getting support from department chairs or supervisors.
Date: Thursday, December 3
Time: 1:00 – 2:00 pm
|
|
Translational Science Interagency Fellowship
The Translational Science Interagency Fellowship (TSIF) program, sponsored by the National Center for Advancing Translational Sciences (NCATS) and the FDA, provides training in both translational and regulatory science. Fellows will be trained in preclinical translational science, technology development and regulatory research and review. This three-year program will enable fellows to build awareness of regulatory requirements into the early stages of medical product development to improve efficiencies in the development and review processes. Applications are due Friday, January 15, 2021. Contact Scott Steele for questions.
|
|
Pilot Awards from the Rochester Roybal Center & UR Aging Institute
The Rochester Roybal Center for Social Ties & Aging Research (The Roc STAR Center) and the UR Aging Institute are co-sponsoring pilot awards focused on promoting the social well-being and healthy aging of those caring for a family member with Alzheimer’s disease or related dementias. There are currently two pilot award opportunities: the STAR Constellation Pilot Award and the ProtoSTAR Pilot Award. Apply by Monday, January 25, 2021.
|
|
RocHealthData Explores Native American Health Disparities
November is Native American Heritage month - a time to recognize and celebrate Native American heritage and culture. The UR CTSI and Center for Community Health and Prevention also want to raise awareness of the long-standing health disparities experienced by American Indian and Alaskan Native communities. Learn more on RocHealthData and visit the map room to view data about Native Americans’ demographics overlaid with information about health disparities in rural areas.
|
|
URMC Startup to Develop Neurological Therapies
Oscine Therapeutics – a biotechnology company that is developing cell-based therapies for neurological disorders based on discoveries made at URMC – has been acquired by Sana Biotechnology. The research behind Oscine is based on decades of work in the lab of Steve Goldman, M.D., Ph.D., professor of Neurology and Neuroscience and co-director of the URMC Center for Translational Neuromedicine. Goldman, who was Oscine’s president and scientific founder, joins Sana as senior vice-president and head of Central Nervous System Therapy. He will also remain on the URMC faculty.
|
|
|
|
|
